The Institute for African Studies under the Russian Academy of Sciences was founded 60 years ago, precisely in 1959. Since then it has undergone various changes and carried out huge scientific research on Africa.
Professor Dmitri Bondarenko, the deputy director, discusses some aspects of its most current achievements, challenges and the future. Here are excerpts from the interview conducted by Kester Kenn Klomegah:
Institute for African Studies marks its 60th year. Can we look at its performance, at least, during the past five years? What are the landmarked activities during the past half a decade?
The 60th anniversary is a good reason for looking both back at the results to date and ahead. If I could speak further about the achievements of the most recent years, I would mention first and formost, we try our best to organize fieldwork in Africa, although we are limited in our possibilities rather rigidly.
The landmark activities during the last five years in the academic sphere are as follows: the 13th and 14th conferences of Africanists (2014, 2017) – this is the Institute’s “brand conference”. Every time, it brings together about 500 participants from all over the world, including many African countries. The next, 15th, conference will take place in May 2020; 48 panels with about 10 presentations in each are included into its preliminary program.
In the last five years, several important conferences were organized together with foreign partners – from Slovenia, Portugal and, what is especially important, from Tanzania. The conference took place in Dar es Salaam in March 2019 and brought together scholars from 13 states. The next conference in Tanzania is scheduled for November 2020.
Several dozen books have been published in the last five years, among probably the most important of which are: Federalism in Africa: Problems and Prospects (in Russian and English), edited by Igho O. Natufe and Khristina M. Turyinskaya (2015), Tropical Africa: Evolution of Political Leadership (in Russian) by Tatiana S. Denisova (2016), Islam, Global Governance and the New World Order (in Russian) by Leonid L. Fituni and Irina O. Abramova (2018).
Assess the importance of its research, in form of consultancy, for government institutions and private both in Russia and Africa?
This importance is definitely growing, especially in the most recent years. State institutions and business companies seek the Institute’s consultancy services more and more often nowadays. In particular, the Institute played an important role in the preparation of the Russia-Africa summit in October 2019.
As we are a research institution, my firm belief is that just academic research should be our primary task. The situation has been changing during the last few years. Today the importance of Africa for Russia in different respects, including political and economic, is recognized by the state, and the Russian Foreign Ministry and other state institutions dealing with the Russian-African relations in various spheres, not just purely political, ask us for our expert advice on different points quite often.
What are the current challenges and hindrances to research Africa these years? Do you have any suggestions here on how to improvement the situation?
The situation now is much better for African studies than for a long time before. In particular, today there are much more opportunities for doing fieldwork in Africa. Russian Africanists and their work are becoming better known in the global Africanist community. Quite a lot of junior researchers join the academy nowadays. In my assessment, African studies in Russia are on the right road.
The challenges our African Studies are facing now are the same as the whole Russian Academy are facing, and they are mainly related to the bureaucratic pressure on research institutions.
How about academic cooperation with similar institutions inside Africa? Do you exchange researchers and share reports with African colleagues?
At the moment, the Institute has Agreements on Cooperation or Memorandums of Understanding with 18 universities and research institutes from 12 African states and currently there are negotiations with two more institutions from one more country.
As noted above, many African scholars come to our conferences, and we had and will have jointly organized conferences with particularly Tanzanian partners. Our partners help organize the Institute researchers’ fieldwork in their countries the outcome of which, besides other points, are joint publications (for example, with our colleagues from Tanzania and Zambia).
It is important to say that African colleagues regularly publish their articles in “The Journal of the Institute for African Studies”. We also have book exchange programs with some of our African partners. However, we do not have well-established exchange of researchers with our African partners, especially because of financial difficulties from both sides.
Besides, I must say that not all African partners, even those with whom we have official Memorandums of Understanding or Agreements on Cooperation, are really active in supporting ties with us, some of them do not initiate any joint projects and remain passive when we propose something. Nevertheless, we do have good and diversified ties with many African partners.
And the future vision for the IAS? How would you like the IAS transform, or say, diversify its activities especially now the Kremlin prioritizes Africa?
As I see it, the Institute’s forseeable future will be based on two main developments. On the one hand, it will more and more become a “think tank” for the state and business, and most probably, this development will dominate.
On the other hand, I hope the Institute will remain as a research institution where fundamental studies into different aspects of African and African diaspora’s past and present are done. The Institute for African Studies has the potential and capacity for combining both trends at a high level and far into the future.
As it becomes clearer from the discussion, I see the prospects for the Institute’s further development, in attracting more young researchers with their energy and new visions and approaches, in extending fieldwork in Africa, and in broadening international cooperation with Africanists worldwide.
African Union’s Inaction on Ethiopia Deplorable – Open Letter
A group of African intellectuals says in an open letter that it is appalled and dismayed by the steadily deteriorating situation in Ethiopia. The letter, signed by 58 people, says the African Union’s lack of effective engagement in the crisis is deplorable. The letter calls on regional bloc IGAD and the AU to “proactively take up their mandates with respect to providing mediation for the protagonists to this conflict”.
The letter also asks for “all possible political support” for the AU’s Special Envoy for the Horn of Africa, Olusegun Obasanjo, whose appointment was announced on August 26, 2021. A United Nations Security Council meeting on the same day welcomed the former Nigerian president’s appointment.
Earlier in August 2021, UN chief Antonio Guterres appealed for a ceasefire, unrestricted aid access and an Ethiopian-led political dialogue. He told the council these steps were essential to preserve Ethiopia’s unity and the stability of the region and to ease the humanitarian crisis. He said that he had been in close contact with Ethiopian Prime Minister Abiy Ahmed and had received a letter from the leader of the Tigray region in response to his appeal. “The UN is ready to work together with the African Union and other key partners to support such a dialogue,” he said.
August 26, 2021 was only the second time during the conflict that the council held a public meeting to discuss the situation. Britain, Estonia, France, Ireland, Norway and the United States requested the session.
Fighting between the national government and the Tigray People’s Liberation Front broke out in November 2020, leaving millions facing emergency or crisis levels of food insecurity, according to the United Nations. Both sides have been accused of atrocities.
Africa: The G20 Must Recommit to Covax
It is one year since the international community gave its backing to the COVID-19 Vaccine Global Access (COVAX) facility to lead a worldwide effort to end the acute phase of the pandemic. The initiative aimed to ensure that every country, and not just those with sufficient money or resources, could access life-saving vaccines once they became available. As G20 health ministers prepare to meet in Rome on September 5-6, they are in a position to ensure that COVAX fulfills its mission.
A year ago, no one knew when or even if it might be possible to develop a safe and effective vaccine against COVID-19, let alone the 20 that are available today. But since making its first international deliveries in February, COVAX a partnership established by the Coalition for Epidemic Preparedness Innovations, the World Health Organization, UNICEF, and Gavi, the Vaccine Alliance has delivered more than 235 million vaccine doses to 139 countries, and expects to deliver another billion doses in the fourth quarter. Only China, India, and the United States have delivered more. This start to the largest and most complex vaccine rollout in history has given hope to millions of people and laid solid foundations for how we respond to future pandemics.
Yet, so much more could, and should, have been achieved by now. It is unacceptable that only 1.8% of people in low-income countries have received their first dose of a COVID-19 vaccine, compared to 82% in high- and upper-middle-income countries. This shocking inequality is as economically senseless as it is destructive to human life, with the latest estimate of the cost of the slow rollout amounting to $2.3 trillion.
The world was woefully unprepared for a pandemic, and this is reflected in the challenges COVAX has faced. By the time initial funding arrived, wealthy countries had already locked up early vaccine supplies. Export bans affecting key suppliers, and difficulties experienced by many manufacturers in scaling up production to the required level, also undermined COVAX’s ability to access doses early.
Given increasing global vaccine inequity and the rise of new, more contagious coronavirus variants, we must put these challenges behind us. Thanks to the support of almost all G20 governments, alongside that of foundations and private businesses, COVAX has now raised nearly $10 billion and secured more than 600 million donated doses. All the preparations are in place for the most comprehensive vaccination effort that the world has seen.
Based on the committed orders COVAX has placed with vaccine manufacturers and the additional donations, hundreds of millions of new doses should now be available each month. We need to make sure they reach poorer countries and get into people’s arms. To avoid further delays, and for the facility to succeed, we need support from G20 leaders in four key areas.
First, we need doses, and we need them now. The premise of COVAX was always that the facility should be able to negotiate and buy its own doses. With our early vaccine access compromised, donations have played a vital role in maintaining our ability to keep doses flowing to those most in need. Of the 600 million doses pledged to COVAX to date, 100 million have now been delivered. We need more, and soon, with longer shelf lives and greater certainty so that recipient countries have time to plan their rollout. This can be achieved without jeopardizing high-income countries’ national vaccination efforts.
We also need G20 leaders to support our call for transparency. COVAX has legally binding agreements with manufacturers for more than four billion doses, but has all too often faced delays in accessing them. Without greater clarity regarding firms’ order books, it is impossible to know whether these holdups are due to production challenges or preferential treatment for bilateral arrangements. Insisting that manufacturers are transparent about their order timelines can ensure a level playing field where no one particularly those living in developing countries gets bumped to the back of the vaccine queue because of another bilateral deal.
In addition to ensuring that manufacturers keep their commitment to COVAX, governments should make global vaccine access their highest priority. Countries with pending orders for doses that they currently do not need should allow COVAX to take their place in the queue so that we can get doses to needy countries now.
Finally, lower-income countries require continued financial and technical support for their COVID-19 vaccine rollouts. Strengthening national health systems will help these countries to ensure delivery of doses and mitigate the pandemic’s secondary effects, and will leave in place infrastructure critical to future global health security.
By recommitting to COVAX, G20 leaders will recommit to a multilateral solution that builds on the astounding scientific progress of the past year. Based on COVAX’s latest forthcoming supply forecast, when topped up with doses through bilateral deals, equitable COVID-19 vaccine access can protect up to 60% of the adult population in 91 lower-income countries. This would represent a huge step toward the WHO target of 70%, which is needed to suppress the coronavirus everywhere, and COVAX represents the best opportunity to achieve it.
Failure would mean more lives lost, broken health-care systems, even deadlier and more transmissible variants, and a pandemic with no end in sight. The G20 must not allow that to be an option.
More African Countries Register Russia’s Sputnik Vaccine
Africa Centres for Disease Control and Prevention (Africa CDC) is a specialized technical institution of the African Union (AU) that strengthens the capacity and capability of Africa’s public health institutions as well as partnerships to detect and respond quickly and effectively to disease threats and outbreaks, based on data-driven interventions and programmes.
During the outbreak of the coronavirus, the African Vaccine Acquisition Task Team (AVATT), was established by African Union, as a component in support of the Africa Vaccine Strategy and was endorsed by the AU Bureau of Heads of State and Government on 20th of August 2020.
Dr John Nkengasong, Director of the Africa Centers for Disease Control and Prevention (Africa CDC), has emphasized: “Africa has to team up with development partners to achieve its 60% continent-wide vaccination in the next two years. I think that is why we should as a collective of the continent, and of course, in partnership with the developed world make sure that Africa has a timely access to vaccines to meet our vaccination targets.”
An official media release in February 2021, the Africa Vaccine Acquisition Task Team from the African Union (AU) informed that Russia would supply and deliver 300 million Sputnik V vaccines to Africa. That step was intended to support African countries to attain their targeted immunization of 60% of the population by the year-end. That vaccine story disappeared, but instead what become so common is the speedy registration of Sputnik V on bilateral basis in various African countries.
According to the latest, Nigeria has become the 68th country in the world to approve the Russian vaccine. The use of the Sputnik V coronavirus vaccine has been approved in Nigeria, the Russian Direct Investment Fund (RDIF) said in an official statement.
“The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the approval of the Russian Sputnik V vaccine against coronavirus by the National Agency for Food and Drug Administration and Control of Nigeria (NAFDAC). Nigeria has become the 68th country in the world to approve the Russian vaccine. Total population of all countries, where Sputnik V is approved for use, now exceeds 3.7 billion people, which is nearly half of the global population,” the statement said.
“Nigeria is the most populous nation in Africa, and the approval of Sputnik V will provide for using one of the safest and most effective vaccines in the world. Sputnik V is based on a proven human adenoviral vectors platform and is successfully used in over 50 countries. Approval in Nigeria will make an important contribution to the country’s fight against the pandemic,” CEO of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said.
Besides Nigeria, other African countries have registered Russia’s Sputnik V vaccine. Reportedly, the vaccine has been registered in Algeria, Angola, Djibouti, Egypt, Gabon, Ghana, Guinea, Kenya, Morocco, Namibia, Tunisia, the Republic of Congo (DRC) and Zimbabwe.
Russia’s drive to share Sputnik V vaccine, of course, offers a chance to raise its image and strengthen alliances in Africa. Ministry of Foreign Affairs of the Russian Federation has made efforts promoting the vaccine using all its channels. But supply and delivery have largely lagged behind, the pledges have simply not been fulfilled. Russian authorities have oftentimes said that they would step up efforts for fruitful cooperation in combating coronavirus in Africa.
Promising more than can be delivered appears to be a universal problem with coronavirus vaccines, and it is a real risk for Russia as well, said Theresa Fallon, Director of the Brussels-based Centre for Russia Europe Asia Studies. “They have won the gold medal for creating this very effective vaccine,” she said. “But the problem is how are they going to implement production and delivery?”
Russian Direct Investment Fund (RDIF), with profit motivation, has attempted supplying the Russian vaccines through, Sheikh Ahmed Dalmook Al Maktoum, from the Monarch family and a third party in Dubai, United Arab Emirates, to a number of African countries. For instance, the Republic of Ghana reportedly signed US$64.6 million contract for Sputnik V vaccine from Russia through Sheikh Ahmed Dalmook Al Maktoum. It was double the price from the producer as reported in the media.
On the other hand, Russian President Vladimir Putin has noted, in a speech early September, that advanced countries that produce vaccines against the coronavirus do little to protect humanity from the pandemic.
“The benefits of vaccination are enjoyed mostly by advanced economies. The bulk of the vaccines is made there, and it is used to protect their own population. But very little is being done to protect humanity in the broad sense,” Putin said at the plenary session of the Eastern Economic Forum in Vladivostok, the Far East of Russia. “This is very bad for the producers, because all this boomerangs around the globe. For instance, in Africa the level of protection with vaccines is minimal, but contacts with the African countries continue. There is no getting away from this. This infection will return again and again.”
According to an official release obtained late February, the Sputnik V vaccine the following advantages:
• Efficacy of Sputnik V is 91.6% as confirmed by the data published in the Lancet, one of the world’s oldest and most respected medical journals; It is one of only three vaccines in the world with efficacy of over 90%; Sputnik V provides full protection against severe cases of COVID-19.
• The Sputnik V vaccine is based on a proven and well-studied platform of human adenoviral vectors, which cause the common cold and have been around for thousands of years.
• Sputnik V uses two different vectors for the two shots in a course of vaccination, providing immunity with a longer duration than vaccines using the same delivery mechanism for both shots.
• The safety, efficacy and lack of negative long-term effects of adenoviral vaccines have been proven by more than 250 clinical studies over two decades.
• The developers of the Sputnik V vaccine are working collaboratively with AstraZeneca on a joint clinical trial to improve the efficacy of AstraZeneca vaccine.
• There are no strong allergies caused by Sputnik V.
• The price of Sputnik V is less than $10 per shot, making it affordable around the world.
In February, peer-reviewed medical journal The Lancet published an analysis from Phase III clinical trial of the Russian vaccine, showing its 91.6-percent efficacy against symptomatic COVID-19. The Sputnik V vaccine was developed by the Gamaleya Research Institute of Epidemiology and Microbiology.
Sputnik V was registered in Russia on August 11, 2020 as the world’s first officially registered coronavirus vaccine. Russian vaccines have advantages as no deaths have been reported after vaccination with the Sputnik V, Alexander Gintsburg, Director of the Gamaleya Center, the vaccine developer, said and was reported by TASS News Agency. “As of today, no deaths after vaccination with Sputnik V have been registered,” he said.
Russian Direct Investment Fund (RDIF) is Russia’s sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management is based in Moscow.
In Africa, during first of September, the coronavirus-related death toll has topped 196,190, while more than 6.9 million recoveries have been reported. South Africa accounts for a majority of coronavirus cases and deaths across Africa – 2,777,659 and 82,261 respectively. The death toll in Tunisia climbed to 23,451, and 664,034 cases have been confirmed. Egypt recorded 16,736 deaths and 288,441 coronavirus cases.
In Sub-Saharan Africa, Ethiopia is ranked second to South Africa (308,134 cases and 4,675 deaths) and is followed by Kenya (235,863 cases and 4,726 deaths) and Nigeria (191,805 and 2,455). The total number of COVID-19 cases has reached almost 8 million in Africa, according to the World Health Organization’s (WHO) Regional Office for Africa.
The Demise of a French Sub Deal: Is China a Threat?
The conflict between emerging and existing powers is almost as old as time. Labeled the Thucydides Trap, it first recounted...
Lighthouse Partnerships Gain Momentum on Social Justice
Crises in climate, health and inequality are compelling organizations to align business strategies with equity and social justice values. In...
AUKUS: Human-made disaster
AUKUS is a new military alliance that emerged recently, among Australia, UK, and The US. Under this alliance, it has...
Visit of Vietnamese President to Cuba
Following the outbreak of the Corona pandemic in Vietnam, the government has decided to procure 10 million doses of Abdala...
Finding Fulcrum to Move the World Economics
Where hidden is the fulcrum to bring about new global-age thinking and escape current mysterious economic models that primarily support...
The failure of the great games in Afghanistan from the 19th century to the present day
Whenever great powers have tried to make Afghanistan a colony, they have always been defeated. British imperialism and its “civilising...
From the 2004 tsunami relief efforts to the 2021 leaders’ summit, the Quad has come a long way
The Quad plurilateral mechanism in the Indo-Pacific reached the landmark summit level in March, this year. With its second summit...
Middle East3 days ago
Turkey’s Destruction of Cultural Heritage in Cyprus, Turkey, Artsakh
Economy3 days ago
A New Strategy for Ukraine
Defense4 days ago
A Glimpse at China’s Nuclear Build-Up
Diplomacy4 days ago
International Relations Amid the Pandemic
International Law4 days ago
The rise & rise of populist demagogues in democratic nations
Southeast Asia3 days ago
Indonesian G20 presidency promises to put a ‘battle for the soul of Islam’ on the front burner
Development4 days ago
Better Targeting of Social Protection Programs can Significantly Reduce Poverty in Bangladesh
Finance4 days ago
Dubai Chamber Continues Bolstering Economic Ties Between UAE And Africa